Publications

Journal Article Ppublish 1536 citations
Open access — free full text available
Open access
Electronic publication date
September 15, 2020

View on Pubmed.gov 32597954 | View on doi.org 10.1182/blood.2... | View the free full text Full text

Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome.

Search for publications in this journal Blood - 136(10):1169-1179

Abstract

COVID-19 affects millions of patients worldwide, with clinical presentation ranging from isolated thrombosis to acute respiratory distress syndrome (ARDS) requiring ventilator support. Neutrophil extracellular traps (NETs) originate from decondensed chromatin released to immobilize pathogens, and they can trigger immunothrombosis. We studied the connection between NETs and COVID-19 severity and progression. We conducted a prospective cohort study of COVID-19 patients (n = 33) and age- and sex-matched controls (n = 17). We measured plasma myeloperoxidase (MPO)-DNA complexes (NETs), platelet factor 4, RANTES, and selected cytokines. Three COVID-19 lung autopsies were examined for NETs and platelet involvement. We assessed NET formation ex vivo in COVID-19 neutrophils and in healthy neutrophils incubated with COVID-19 plasma. We also tested the ability of neonatal NET-inhibitory factor (nNIF) to block NET formation induced by COVID-19 plasma. Plasma MPO-DNA complexes increased in COVID-19, with intubation (P < .0001) and death (P < .0005) as outcome. Illness severity correlated directly with plasma MPO-DNA complexes (P = .0360), whereas Pao2/fraction of inspired oxygen correlated inversely (P = .0340). Soluble and cellular factors triggering NETs were significantly increased in COVID-19, and pulmonary autopsies confirmed NET-containing microthrombi with neutrophil-platelet infiltration. Finally, COVID-19 neutrophils ex vivo displayed excessive NETs at baseline, and COVID-19 plasma triggered NET formation, which was blocked by nNIF. Thus, NETs triggering immunothrombosis may, in part, explain the prothrombotic clinical presentations in COVID-19, and NETs may represent targets for therapeutic intervention.

References

Front Microbiol. 2018 Dec 21;9:3174

J Clin Invest. 2016 Oct 3;126(10):3783-3798

Nat Rev Immunol. 2013 Jan;13(1):34-45

Front Immunol. 2016 Sep 19;7:366

Cited by 1536 citations (total)

Journal Article Review

Severe Acute Respiratory Syndrome-Associated Coronavirus 2 Infection and Organ Dysfunction in the ICU: Opportunities for Translational Research.

Electronic publication date April 1, 2021

Search for publications in this journal Crit Care Explor

Philip A Verhoef [...] Kenneth E Remy et al.

OBJECTIVES

Since the beginning of the coronavirus disease 2019 pandemic, hundreds of thousands of patients have been treated in ICUs across...

Systematic Review

Immunothrombosis in Acute Respiratory Dysfunction of COVID-19.

Electronic publication date June 25, 2021

Search for publications in this journal Front Immunol

Xiang-Zhi Fang [...] You Shang et al.

COVID-19 is an acute, complex disorder that was caused by a new β-coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)....

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances